Home/Investors/Versant Ventures Versant Ventures
Biotech Investor · 18 portfolio companies
Portfolio Companies
| Company | Stage | Valuation | Focus |
|---|
| Monte Rosa Therapeutics | Phase 2 | $1.7B | Oncology, Immunology |
| Century Therapeutics | Phase 1 | $405.8M | Oncology, Autoimmune Diseases |
| Convexia | preclinical | — | Neuroscience, Neurodegenerative Diseases |
| Belharra Therapeutics | preclinical | — | Oncology, Immunology |
| Vicinitas Therapeutics | preclinical | — | Oncology, Rare Disease |
| Atom Bioscience | phase-2 | — | Immunology, Autoimmune Diseases |
| Perimeter Systems, Inc. | preclinical | — | Oncology |
| Helicore Biopharma | Pre-clinical | — | Obesity, Metabolic Disease |
| Firefly Bio | Pre-clinical | — | Oncology |
| Granite Bio | Phase 1 | — | Inflammation, Autoimmunity |
| Anokion | Phase 2 | — | Autoimmune Diseases, Celiac Disease |
| Capsida Biotherapeutics | Phase 1 | — | Neurology, Rare Diseases |
| Enterprise Therapeutics | Phase 1 | — | Cystic Fibrosis, Asthma |
| Jnana Therapeutics | phase-1 | — | Immunology, Metabolic |
| Abdera Therapeutics | preclinical | — | Oncology |
| Timberlyne Therapeutics | preclinical | — | Neuroscience, Psychiatry |
| BioRegen | phase-2 | — | Regenerative Medicine, Autoimmune |
| VitaCell Biologics | preclinical | — | Cardiovascular, Neurology |